Regenerative proliferation of differentiated cells by mTORC1‐dependent paligenosis |
| |
Authors: | Dengqun Liu Megan D Radyk Rebecca L Cunningham Joseph Burclaff Greg Sibbel Hei‐Yong G Lo Valerie Blanc Nicholas O Davidson Zhen‐Ning Wang Jason C Mills |
| |
Affiliation: | 1. State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, College of Preventive Medicine, Third Military Medical University, Chongqing, China;2. Division of Gastroenterology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA;3. Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA;4. Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China;5. Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA |
| |
Abstract: | In 1900, Adami speculated that a sequence of context‐independent energetic and structural changes governed the reversion of differentiated cells to a proliferative, regenerative state. Accordingly, we show here that differentiated cells in diverse organs become proliferative via a shared program. Metaplasia‐inducing injury caused both gastric chief and pancreatic acinar cells to decrease mTORC1 activity and massively upregulate lysosomes/autophagosomes; then increase damage associated metaplastic genes such as Sox9; and finally reactivate mTORC1 and re‐enter the cell cycle. Blocking mTORC1 permitted autophagy and metaplastic gene induction but blocked cell cycle re‐entry at S‐phase. In kidney and liver regeneration and in human gastric metaplasia, mTORC1 also correlated with proliferation. In lysosome‐defective Gnptab?/? mice, both metaplasia‐associated gene expression changes and mTORC1‐mediated proliferation were deficient in pancreas and stomach. Our findings indicate differentiated cells become proliferative using a sequential program with intervening checkpoints: (i) differentiated cell structure degradation; (ii) metaplasia‐ or progenitor‐associated gene induction; (iii) cell cycle re‐entry. We propose this program, which we term “paligenosis”, is a fundamental process, like apoptosis, available to differentiated cells to fuel regeneration following injury. |
| |
Keywords: | dedifferentiation regeneration repair reprogramming transdifferentiation |
|
|